Covaxin shows 78 pc efficacy against mild to severe COVID-19: Bharat Biotech

| | New Delhi
1 2 3 4 5
  • 0

Covaxin shows 78 pc efficacy against mild to severe COVID-19: Bharat Biotech

Wednesday, 21 April 2021 | PTI | New Delhi

Covaxin shows 78 pc efficacy against mild to severe COVID-19: Bharat Biotech

Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown efficacy of 78 per cent against mild, moderate and severe cases of COVID-19, as per Phase III interim analysis results.

The vaccine maker noted that the second interim data of the Phase III study also showed that chances of hospitalisation due to the infectious disease were reduced by 100 per cent after taking the Covaxin jab.

Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 per cent against mild, moderate, and severe COVID-19 disease, Bharat Biotech said in a statement.

 

Trending News

more

State Editions

Rajnath attacks AAP's for rejecting Central aid

03 February 2025 | Staff Reporter | Delhi

Jaishankar enters poll fray in Delhi Assembly election

03 February 2025 | Staff Reporter | Delhi

Maken claims AAP hurting public services

03 February 2025 | Staff Reporter | Delhi

Sarma blames Kejriwal for Yamuna's condition

03 February 2025 | Staff Reporter | Delhi

BJP bribing, suppressing voters in Delhi: Kejriwal

03 February 2025 | Staff Reporter | Delhi

Rajnath attacks AAP's for rejecting Central aid

03 February 2025 | Staff Reporter | Delhi

Sunday Edition

The master of villainy

02 February 2025 | SAKSHI PRIYA | Agenda

Where Ambience Meets Flavour

02 February 2025 | Abhi Singhal | Agenda

Italy’s Best, Served Here

02 February 2025 | Gyaneshwar Dayal | Agenda

The Divine Glow of Ayodhya

02 February 2025 | Hemant Shukla | Agenda

Explore Goa Like Never Before!

02 February 2025 | Sharmila Chand | Agenda

The master of villainy

02 February 2025 | SAKSHI PRIYA | Agenda

Where Ambience Meets Flavour

02 February 2025 | Abhi Singhal | Agenda